Companies
Analysts Offer Important Insight On Keros Therapeutics Inc (KROS)
Keros Therapeutics Inc (NASDAQ:KROS) concluded the trading at $58.61 on Friday, April 12 with a fall of -5.32% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $61.90 and 5Y monthly beta
